Picture of Champions Oncology logo

CSBR Champions Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Champions Oncology Inc reports results for the quarter ended in October - Earnings Summary

* Champions Oncology Inc  CSBR.OQ  reported quarterly adjusted
earnings of 2 cents​​ per share for the quarter ended in
October. The mean expectation of three analysts for the quarter
was for earnings of one cents per share.
* Revenue rose 16.5% to $11.79 million from a year ago; 
analysts expected $11.55 million. 
* Champions Oncology Inc's reported EPS for the quarter was 2
cents​.
* The mean earnings estimate of analysts had fallen by
about 83.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Champions Oncology Inc shares had fallen by 20.2% this
quarter and lost 24.5% so far this year.
* The company reported quarterly net income of $277 thousand.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated December 13 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Champions Oncology

See all news